Atlas Trials

Genetics of Response to Canagliflozin

Clinical trial NCT02891954 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02891954
Sponsor
University of Maryland, Baltimore
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2016-09-01
Primary completion
2023-09-25
Enrollment
700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.